Effects of recombinant leptin therapy in a child with congenital leptin deficiency
Effects of recombinant leptin therapy in a child with congenital leptin deficiency
复制标题
DOI:
10.1056/nejm199909163411204
复制
发表时间:
1999-09-16
影响因子:
158.5
通讯作者:
O'Rahilly, S
中科院分区:
文献类型:
--
作者:
Farooqi, IS;Jebb, SA;O'Rahilly, S
Severely obese (ob/ob) mice are deficient in the adipocyte-derived hormone leptin, which acts on the hypothalamus to control appetite and energy expenditure.1The administration of leptin to these mice corrects their obesity by reducing their food intake and increasing their energy expenditure.2–4These mice also have hyperinsulinemia, corticosterone excess, and infertility, which also are reversed by treatment with leptin.5In humans, serum leptin concentrations, in general, correlate positively with indexes of obesity.6,7We previously described two cousins with severe, early-onset obesity and undetectable serum leptin concentrations who were homozygous for a frame-shift mutation in the leptin . . .